Regulated information
2023 periodic and ongoing information
Periodic information and presentations
Not all documents are available in English. We apologize for the inconvenience and invite you to check the Regulated Information section in the French version of our website.
27/09/2023 – Half-year results 2023 – Presentation
05/06/2023 – Universal Registration Document (URD) 2022 – PDF
Press releases
Not all documents are available in English. We apologize for the inconvenience and invite you to check the Regulated Information section in the French version of our website.
14/12/2023 – LUMIBIRD ADJUSTS ITS 2023 GROWTH TARGET
24/11/2023 – LUMIBIRD CLARIFIES ITS INTENTIONS REGARDING CILAS
15/11/2023 – QUANTEL MEDICAL ONE OF THE FIRST WINNERS OF THE FRANCE 2030 “MEDICAL IMAGING” CALL FOR PROJECTS
24/10/2023 – Revenues Q3 2023
14/09/2023 – LUMIBIRD: MAJOR CONTRACT SIGNED FOR LASER RANGEFINDERS FOR DEFENCE APPLICATIONS
31/08/2023 – LUMIBIRD COMPLETES ACQUISITION OF PRIMA INDUSTRIE’S HIGH POWER LASER AND SEMICONDUCTOR BUSINESSES IN ITALY AND THE UNITED STATES
24/07/2023 – 2023 Half-Year earnings
24/07/2023 – Revenues S1 2023
16/05/2023 – LUMIBIRD ANNOUNCES AGREEMENT TO ACQUIRE PRIMA INDUSTRIE’S HIGH POWER LASER AND SEMICONDUCTOR BUSINESSES IN ITALY AND THE UNITED STATES
24/04/2023 – Revenues Q1 2023
17/04/2023 – LUMIBIRD RECEIVES MARKETING APPROVAL IN CHINA FOR ITS VITRA 2 PHOTOCOAGULATOR
14/03/2023 – FY 2022 results
30/01/2023 – FY 2022 revenues of €191m (+18%)
Proxy material for AGMs
Not all documents are available in English. We apologize for the inconvenience and invite you to check the Regulated Information section in the French version of our website.
07/04/2023 – Management Report
07/04/2023 – Meeting notice
07/04/2023 – Voting form
07/04/2023 – Request for documentation
24/03/2023 – Access to preparatory documents for the combined General Meeting on April 28, 2023
24/03/2023 – Avis de réunion Balo du 24 mars 2023 (in French)
24/03/2023 – Rapport du Conseil d’administration sur les résolutions (in French)
Monthly Statement on Share Capital and Voting Rights
Not all documents are available in English. We apologize for the inconvenience and invite you to check the Regulated Information section in the French version of our website.
Other
Not all documents are available in English. We apologize for the inconvenience and invite you to check the Regulated Information section in the French version of our website.
Investors relations and financial communications
Mathieu CALLEUX
Société Calyptus
(+33) 1 53 65 37 91
lumibird@calyptus.net
Fabienne FOUCAULT
Executive Assistant
(+33) 1 69 29 17 21
ffoucault@lumibird.com
Application areas of the group
Industrial & scientific
Defense & Space
LiDAR sensors
Medical
Application areas of the group
Industrial & scientific
Defense & Space
LiDAR sensors
PHOTONICS
MEDICAL
Solid-state lasers,
laser diodes
& components
Fiber lasers & fiber amplifiers
Photonics solutions for time of flight LiDAR and range-finding
Doppler LiDAR systems for wind measurement
Innovative medical and ophthalmological solutions from diagnosis to laser treatment
LUMIBIRD